Search

Rong L Liu

from El Monte, CA
Age ~75
Get Report
Also known as:
Rong Liang Liu, Rong Lieng Liu, Hong Zheng Liu, Hong Zhen Liu, Hong Z Liu, Rong Z Liu, Hong Bowie Liu, Zhen Hong Liu, Zhen Liu Hong, Liu Zhen Hong
Related to:
Xi Zhe Liang, 67Zi P Li, 39Xiao Y Liang, 61Li Lin, 45Min LiuPing Liang
Connected to:
Abby Liu, 37Alba Liu, 48Alina Y Liu, 53Annan R Liu, 53Antong Liu, 35Anwei Liu, 62Bai Liu, 66Bao Liu, 51Baoxian Liu, 55Bella C Liu, 101

Rong Liu Phones & Addresses

  • El Monte, CA
  • New York, NY
  • Arcadia, CA
  • S El Monte, CA
  • Los Angeles, CA
  • Temple City, CA

Professional Records

Lawyers & Attorneys

Rong Liu Photo 1

Rong Liu - Lawyer

View page
Specialties:
Intellectual Property
ISLN:
1000744258
Admitted:
2015

Resumes

Resumes

Rong Liu Photo 2

Rong Min Liu Union City, CA

View page
Work:
Foxconn NWE Technology Inc.

Apr 2011 to 2000
Engineering Program Manager
Foxconn NWE Technology Inc.
Santa Clara, CA
Aug 2010 to Apr 2011
Mechanical Engineer
Quanta Computer Inc.
Fremont, CA
Feb 2010 to Aug 2010
Project Engineer
Education:
University of California-Los Angeles (UCLA)
Los Angeles, CA
2005 to 2009
Bachelor of Science in Mechanical Engineering
Skills:
Solid Works, ProE, Agile, Microsoft Office, SAP, Sheet Metal, plastic Injection Molding, Project Management

Business Records

Name / Title
Company / Classification
Phones & Addresses
Rong Z. Liu
Principal
New Creative Nail Spa
Physical Fitness Facility
421 New Lots Ave, Brooklyn, NY 11207
657 57 St, Brooklyn, NY 11220
Rong Liu
CEO, Chairman, President
Austarpharma, LLC
Mfg Pharmaceutical Preparations
18 Mayfield Ave, Edison, NJ 08837
(732) 225-8850
Rong Liu
Mbr
Marcum Bernstein & Pinchuk Llp
Accounting/Auditing/Bookkeeping
750 3 Ave, New York, NY 10017
750 3 Ave, Fl11, New York, NY 10017
(212) 485-5500, (212) 485-5501
Rong Liu
Shu Feng Yuan, LLC
Chinese Restaurant
18459 Colima Rd, Whittier, CA 91748
Rong Liu
SAGE INTERNATIONAL INC
Rong Liu
President
SHU FENG, INC
Nonclassifiable Establishments
2079 S Atlantic Blvd #E, Monterey Park, CA 91754
809 S Atlantic Blvd, Monterey Park, CA 91754
639 W Garvey Ave, Monterey Park, CA 91754
Rong Liu
MEDPOWER INC
Rong Liu
Owner
Number One Photo
Photofinishing Laboratory
1324 Ave U, Brooklyn, NY 11229
(718) 336-4428

Publications

Us Patents

Methods Of Identifying G-Couple Receptors Associated With Macrophage-Trophic Hiv, And Diagnostic And Therapeutic Uses Thereof

View page
US Patent:
7129055, Oct 31, 2006
Filed:
Dec 11, 2000
Appl. No.:
09/734221
Inventors:
Dan R. Littman - New York NY, US
Hongkui Deng - Worcester MA, US
Wilfried Ellmeier - New York NY, US
Nathaniel R. Landau - New York NY, US
Rong Liu - New York NY, US
Assignee:
New York University - New York NY
International Classification:
C01N 33/53
C01N 33/533
C12N 15/00
C12N 15/48
C12N 15/07
C12N 15/09
C12N 5/28
C07K 16/28
US Classification:
435 72, 435 721, 435 724, 435 78, 435 793, 435325, 435 691, 435440, 53038822
Abstract:
Entry of HIV-1 into target cells requires cell surface CD4 as well as additional host cell cofactors. A cofactor required for infection with virus adapted for growth in transformed T cell lines was recently identified and named fusin. Fusin, however, does not promote entry of macrophage-tropic viruses that are believed to be the key pathogenic strains in vivo. It has now been determined that the principal cofactor for entry mediated by the envelope glycoproteins of primary macrophage-tropic strains of HIV-1 is CC-CKR5, a receptor for the β-chemokines RANTES, MIP-1α, and MIP-1β.

Peptide Viral Entry Inhibitors

View page
US Patent:
7592315, Sep 22, 2009
Filed:
Nov 1, 2005
Appl. No.:
11/264509
Inventors:
Rong Liu - Scotch Plains NJ, US
Rumin Zhang - Edison NJ, US
Rong Kong - Scotch Plains NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
A01N 37/18
A61K 38/16
A61K 38/21
A61K 39/42
G01N 33/00
US Classification:
514 13, 514 8, 514 11, 514 5, 514 6, 514 9, 514 7, 436 87, 530317, 530326, 435 691
Abstract:
The present invention provides, inter alia, peptide compositions and methods for treating and preventing Flaviviridae virus (e. g. , hepatitis C virus) infections.

Peptide Viral Entry Inhibitors

View page
US Patent:
20100119483, May 13, 2010
Filed:
Jul 23, 2009
Appl. No.:
12/508095
Inventors:
Rong Liu - Scotch Plains NJ, US
Rumin Zhang - Edison NJ, US
Rong Kong - Scotch Plains NJ, US
International Classification:
A61K 38/21
C07K 2/00
A61K 38/02
A61K 39/395
C07H 21/00
C12N 15/74
C12N 5/071
C12P 21/02
A61P 31/12
A61P 31/14
A61P 31/18
A61P 37/04
US Classification:
424 857, 530300, 514 2, 4241301, 424 854, 536 231, 4353201, 435325, 435 691
Abstract:
The present invention provides, inter alia, peptide compositions and methods for treating and preventing Flaviviridae virus (e.g., HCV) infections.

Modeling A Composite Application

View page
US Patent:
20100250228, Sep 30, 2010
Filed:
Mar 30, 2009
Appl. No.:
12/413749
Inventors:
David Cohn - Dobbs Ferry NY, US
Pankaj Dhoolia - New Delhi, IN
Hemesh Kumar - New Delhi, IN
Santhosh Kumaran - Peekskill NY, US
Rong Liu - Sterling VA, US
Florian Pinel - New York NY, US
Assignee:
International Business Machines Corporation - Armonk NY
International Classification:
G06F 9/45
US Classification:
703 22, 718100
Abstract:
Techniques for modeling a composite application are provided. The techniques include identifying one or more entities that are processed in a user enterprise, identifying one or more actions to be performed during a lifecycle of the one or more entities, and modeling a composite application based on the one or more actions to be performed during a lifecycle of the one or more entities.

Creation Of Flexible Workflows Using Artifacts

View page
US Patent:
20120297390, Nov 22, 2012
Filed:
May 17, 2011
Appl. No.:
13/109560
Inventors:
Richard B. Hull - Chatham NJ, US
Rong Liu - Sterling VA, US
Anil Nigam - Stamford CT, US
Florian Pinel - New York NY, US
Frederick Y. Wu - Greenwich CT, US
Assignee:
INTERNATIONAL BUSINESS MACHINES CORPORATION - Armonk NY
International Classification:
G06F 9/46
US Classification:
718102
Abstract:
Execution of flexible workflows using artifacts is described. A workflow execution engine is configured to instantiate a process execution (PE) artifact. The PE artifact includes one or more transitions. The workflow execution engine is further configured to execute the one or more transitions and determine if any of the one or more transitions are new or modified. The workflow execution engine is additionally configured to load and execute new or modified transitions, without reinstantiating the PE artifact, responsive to determining that at least one new or modified transitions exist.

Methods Of Identifying G-Coupled Receptors Associated With Macrophage-Trophic Hiv, And Diagnostic And Therapeutic Uses Thereof

View page
US Patent:
62585274, Jul 10, 2001
Filed:
May 21, 1997
Appl. No.:
8/861105
Inventors:
Dan R. Littman - New York NY
Hongkui Deng - Worcester MA
Wilfried Ellmeier - New York NY
Nathaniel R. Landau - New York NY
Rong Liu - New York NY
Assignee:
The Aaron Diamond Aids Research Center - New York NY
New York University - New York NY
International Classification:
C12Q 170
G01N 33567
C12N 510
US Classification:
435 5
Abstract:
Entry of HIV-1 into target cells requires cell surface CD4 as well as additional host cell cofactors. A cofactor required for infection with virus adapted for growth in transformed T cell lines was recently identified and named fusin. Fusin, however, does not promote entry of macrophage-tropic viruses that are believed to be the key pathogenic strains in vivo. It has now been determined that the principal cofactor for entry mediated by the envelope glycoproteins of primary macrophage-tropic strains of HIV-1 is CC-CKR5, a receptor for the. beta. -chemokines RANTES, MIP-1. alpha. , and MIP-1. beta.

Hiv Coreceptor Mutants

View page
US Patent:
60571020, May 2, 2000
Filed:
Aug 8, 1997
Appl. No.:
8/907468
Inventors:
Nathaniel R. Landau - New York NY
Richard A. Koup - Southlake TX
Rong Liu - New York NY
William Paxton - Amsterdam, NL
Assignee:
The Aaron Diamond Aids Research Center - New York NY
International Classification:
C12Q 168
C12Q 170
US Classification:
435 6
Abstract:
Entry of HIV-1 into target cells requires cell surface CD4 as well as additional host cell cofactors. A cofactor required for infection with virus adapted for growth in transformed T cell lines was recently identified and named fusin. Fusin, however, does not promote entry of macrophage-tropic viruses that are believed to be the key pathogenic strains in vivo. It has now been determined that the principal cofactor for entry mediated by the envelope glycoproteins of primary macrophage-tropic strains of HIV-1 is CC-CKR5, a receptor for the. beta. -chemokines RANTES, MIP-1. alpha. , and MIP-1. beta. It has also been found that individuals who are homozygous for a mutation of the CKR-5 receptor are resistent to HIV infection; in vitro infection requires a 1000-fold higher dose of HIV than normal cells. The mutation results in complete suppression of CKR-5 expression.

G-Coupled Receptors Associated With Macrophage-Trophic Hiv, And Diagnostic And Therapeutic Uses Thereof

View page
US Patent:
59393203, Aug 17, 1999
Filed:
Jun 19, 1996
Appl. No.:
8/666020
Inventors:
Dan R. Littman - New York NY
Hongkui Deng - New York NY
Wilfried Ellmeier - New York NY
Nathaniel R. Landau - New York NY
Rong Liu - New York NY
Assignee:
New York University - New York NY
The Aaron Diamond Aids Research Center - New York NY
International Classification:
C12N 506
C12N 510
C12N 508
US Classification:
435325
Abstract:
Entry of HIV-1 into target cells requires cell surface CD4 as well as additional host cell cofactors. A cofactor required for infection with virus adapted for growth in transformed T cell lines was recently identified and named fusin. Fusin, however, does not promote entry of macrophage-tropic viruses that are believed to be the key pathogenic strains in vivo. It has now been determined that the principal cofactor for entry mediated by the envelope glycoproteins of primary macrophage-tropic strains of HIV-1 is CC-CKR5, a receptor for the. beta. -chemokines RANTES, MIP-1. alpha. , and MIP-1. beta.

Isbn (Books And Publications)

Water-Insoluble Drug Formulation

View page
Author

Rong Liu

ISBN #

0849396441

Control profile
Rong L Liu from El Monte, CA, age ~75 Get Report